Immunoglobulin G oligoclonal bands in CSF are highly prevalent in MS and CIS, with positive status associated with a significantly earlier age of disease onset.
Despite showing preclinical promise, granulocyte colony-stimulating factor (G-CSF) fails to improve clinical outcomes in acute ischemic stroke patients, according to results published online August 20 ...
We conducted a single institution retrospective analysis on 83 consecutive hematopoietic stem cell mobilization attempts performed in patients with MM. Among them, 56 patients had received ...
Please provide your email address to receive an email when new articles are posted on . In certain settings. Whether a patient has cancer or not, we are trained to reach into our toolbox for whatever ...
The myeloablative therapy before SCT is associated with prolonged pancytopenia, which can result in serious morbidity and life-threatening complications due to infections and bleeding. 9 ...
Clinical studies examining the use of G-CSF in critically ill patients without hematologic disease and immunosuppression included mostly patients with severe sepsis and septic shock. These studies ...
Granulocyte-colony stimulating factors (G-CSFs) reduce the risk of febrile neutropenia in patients with cancer. This study evaluates the clinical and nonclinical value associated with G-CSFs.
Based on long-term observations, granulocyte colony-stimulating factor utilization is a safe and effective treatment to prevent infections and improve quality of life in patients with cyclic ...
The persuasive Global G-CSF/PEG-G-CSF Market report suggests that the key market players are making moves like product launches, joint ventures, developments, mergers and acquisitions which has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback